Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375815 · ClinicalTrials.gov registry record · NA
Statin Choice Decision Aid Implementation First Phase
A NA study of Cardiovascular Factor Risk, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 313
- Enrollment target
- 4
- Study locations
NCT02375815: Completed NA study of Cardiovascular Factor Risk, sponsored by Mayo Clinic.
NCT02375815 is a NA study of Cardiovascular Factor Risk that has completed, run by Mayo Clinic. The registered enrollment target is 313 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02375815, a NA study of Cardiovascular Factor Risk, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 313 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is designed to answer a key question in the field of implementation science. Specifically, it seeks to determine if a proposed model for the implementation and scale-up of healthcare innovations (the AIDED model) is effective and useful. To fully evaluate the potential of this model, the investigators will conduct a multi-year study comprising 3 phases. This proposal represents the first of these phases.
Conditions Studied
Interventions
- OTHER Statin Choice Implementation
Study Locations (4)
Idaho
- Kootenai Health - Coeur d'Alene
Minnesota
- Mayo Clinic in Rochester - Rochester
Missouri
- Mosaic Life Care - Saint Joseph
North Dakota
- Altru Health System - Grand Forks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT02375815 record still lists
NCT02375815 is an interventional study that assigns participants to a tested intervention. The registered 313 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Cardiovascular Factor Risk appearing as the primary indexed condition, and to 1 intervention - of which Statin Choice Implementation is the first listed.
NCT02375815 reports a single indexed study location in Idaho, Minnesota, Missouri.
Frequently Asked Questions
What is clinical trial NCT02375815 about?
NCT02375815 is a clinical study titled "Statin Choice Decision Aid Implementation First Phase". This study is designed to answer a key question in the field of implementation science. Specifically, it seeks to determine if a proposed model for the implementation and scale-up of healthcare innovations (the AIDED model) is effective and useful. To fully evaluate the potential of this model, the ...
What is the current status of trial NCT02375815?
This trial is currently completed. It is a NA study. The enrollment target is 313 participants. The study started on 2015-01. Estimated completion is 2017-03.
What conditions does trial NCT02375815 study?
This clinical trial studies the following conditions: Cardiovascular Factor Risk.
What interventions are being tested in trial NCT02375815?
The interventions under investigation include: Statin Choice Implementation (OTHER).
Who is sponsoring clinical trial NCT02375815?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02375815 being conducted?
This trial has 4 study locations across Idaho, Minnesota, Missouri, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02375815's enrollment target sits among peer trials
313 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00595491 · 313 participants · Phase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia